369 related articles for article (PubMed ID: 27412443)
1. Long-term outcome of patients with ANCA-associated vasculitis treated with plasma exchange: a retrospective, single-centre study.
Frausová D; Hrušková Z; Lánská V; Lachmanová J; Tesař V
Arthritis Res Ther; 2016 Jul; 18():168. PubMed ID: 27412443
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome of severe alveolar haemorrhage in ANCA-associated vasculitis: a retrospective cohort study.
Hruskova Z; Casian AL; Konopasek P; Svobodova B; Frausova D; Lanska V; Tesar V; Jayne DR
Scand J Rheumatol; 2013; 42(3):211-4. PubMed ID: 23374071
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear.
Walsh M; Casian A; Flossmann O; Westman K; Höglund P; Pusey C; Jayne DR;
Kidney Int; 2013 Aug; 84(2):397-402. PubMed ID: 23615499
[TBL] [Abstract][Full Text] [Related]
4. Double positivity for antineutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane antibody could predict end-stage renal disease in ANCA-associated vasculitis: a monocentric pilot study.
Yoo BW; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Rheumatol; 2020 Mar; 39(3):831-840. PubMed ID: 31802348
[TBL] [Abstract][Full Text] [Related]
5. Early plasma exchange improves outcome in PR3-ANCA-positive renal vasculitis.
Gregersen JW; Kristensen T; Krag SR; Birn H; Ivarsen P
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S39-47. PubMed ID: 22510451
[TBL] [Abstract][Full Text] [Related]
6. Plasma exchanges for the treatment of severe systemic necrotizing vasculitides in clinical daily practice: Data from the French Vasculitis Study Group.
de Luna G; Chauveau D; Aniort J; Carron PL; Gobert P; Karras A; Marchand-Adam S; Maurier F; Hatron PY; Mania A; le Guenno G; Bally S; Bienvenu B; Cardineau E; Goulenok T; Jourde-Chiche N; Samson M; Huart A; Pourrat J; Tiple A; Aumaitre O; Puéchal X; Heshmati F; le Jeunne C; Mouthon L; Guillevin L; Terrier B;
J Autoimmun; 2015 Dec; 65():49-55. PubMed ID: 26330347
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of protein A immunoadsorption and therapeutic plasma exchange in ANCA-associated vasculitis with severe renal involvement: a retrospective study.
Liu X; Xia M; Liu D; Liu H; Tang C; Chen G; Liu Y; Yuan F; Liu H
Ann Med; 2023 Dec; 55(1):2230875. PubMed ID: 37452682
[TBL] [Abstract][Full Text] [Related]
8. Clinical implication of plasma exchange on life-threatening antineutrophil cytoplasmic antibody-associated vasculitis.
Park PG; Yoo BW; Song JJ; Park YB; Lee SW
BMC Pulm Med; 2020 May; 20(1):147. PubMed ID: 32466756
[TBL] [Abstract][Full Text] [Related]
9. Survival of patients with ANCA-associated vasculitis on chronic dialysis: data from the French REIN registry from 2002 to 2011.
Romeu M; Couchoud C; Delarozière JC; Burtey S; Chiche L; Harlé JR; Gondouin B; Brunet P; Berland Y; Jourde-Chiche N
QJM; 2014 Jul; 107(7):545-55. PubMed ID: 24570478
[TBL] [Abstract][Full Text] [Related]
10. Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients.
McAdoo SP; Tanna A; Hrušková Z; Holm L; Weiner M; Arulkumaran N; Kang A; Satrapová V; Levy J; Ohlsson S; Tesar V; Segelmark M; Pusey CD
Kidney Int; 2017 Sep; 92(3):693-702. PubMed ID: 28506760
[TBL] [Abstract][Full Text] [Related]
11. High anti-neutrophil cytoplasmic antibody titers are associated with the requirement of permanent dialysis in patients with myeloperoxidase-ANCA-associated vasculitis.
Yen CL; Tian YC; Wu HH; Tu KH; Liu SH; Lee CC; Fang JT; Yang CW; Li YJ
J Formos Med Assoc; 2019 Oct; 118(10):1408-1415. PubMed ID: 31133523
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Severe Kidney Disease.
Casal Moura M; Irazabal MV; Eirin A; Zand L; Sethi S; Borah BJ; Winters JL; Moriarty JP; Cartin-Ceba R; Berti A; Baqir M; Thompson GE; Makol A; Warrington KJ; Thao V; Specks U; Fervenza FC
J Am Soc Nephrol; 2020 Nov; 31(11):2688-2704. PubMed ID: 32826324
[TBL] [Abstract][Full Text] [Related]
13. ANCA associated vasculitis: experience of a tertiary care referral center.
Chaudhry R; Bilal A; Austin A; Mehta S; Salman L; Foulke L; Feustel P; Zuckerman R; Asif A
J Bras Nefrol; 2019; 41(1):55-64. PubMed ID: 30095143
[TBL] [Abstract][Full Text] [Related]
14. Long-term Prognosis of Anti-Neutrophil Cytoplasmic Antibody-Negative Renal Vasculitis: Cohort Study in Korea.
Lee SW; Yu MY; Baek SH; Ahn SY; Kim S; Na KY; Chae DW; Chin HJ
J Korean Med Sci; 2016 Apr; 31(4):542-6. PubMed ID: 27051237
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and outcomes of childhood-onset ANCA-associated vasculitis: a French nationwide study.
Sacri AS; Chambaraud T; Ranchin B; Florkin B; Sée H; Decramer S; Flodrops H; Ulinski T; Allain-Launay E; Boyer O; Dunand O; Fischbach M; Hachulla E; Pietrement C; Le Pogamp P; Stephan JL; Belot A; Nivet H; Nobili F; Guillevin L; Quartier P; Deschênes G; Salomon R; Essig M; Harambat J
Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i104-12. PubMed ID: 25676121
[TBL] [Abstract][Full Text] [Related]
16. Renal vasculitis presenting with acute kidney injury.
Villacorta J; Diaz-Crespo F; Acevedo M; Cavero T; Guerrero C; Praga M; Fernandez-Juarez G
Rheumatol Int; 2017 Jun; 37(6):1035-1041. PubMed ID: 28289874
[TBL] [Abstract][Full Text] [Related]
17. Plasma exchange for the management of ANCA-associated vasculitis: the con position.
Specks U; Fussner LA; Cartin-Ceba R; Casal Moura M; Zand L; Fervenza FC
Nephrol Dial Transplant; 2021 Jan; 36(2):231-236. PubMed ID: 33374017
[TBL] [Abstract][Full Text] [Related]
18. Rituximab for treatment of severe renal disease in ANCA associated vasculitis.
Geetha D; Hruskova Z; Segelmark M; Hogan J; Morgan MD; Cavero T; Eriksson P; Seo P; Manno RL; Dale J; Harper L; Tesar V; Jayne DR
J Nephrol; 2016 Apr; 29(2):195-201. PubMed ID: 25986390
[TBL] [Abstract][Full Text] [Related]
19. Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Results of an International Randomized Controlled Trial (PEXIVAS).
Fussner LA; Flores-Suárez LF; Cartin-Ceba R; Specks U; Cox PG; Jayne DRW; Merkel PA; Walsh M;
Am J Respir Crit Care Med; 2024 May; 209(9):1141-1151. PubMed ID: 38346237
[No Abstract] [Full Text] [Related]
20. Plasma exchange in ANCA-associated vasculitis: the pro position.
Kronbichler A; Shin JI; Wang CS; Szpirt WM; Segelmark M; Tesar V
Nephrol Dial Transplant; 2021 Jan; 36(2):227-231. PubMed ID: 33374018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
